Journal of International Oncology ›› 2013, Vol. 40 ›› Issue (8): 643-645.

Previous Articles     Next Articles

Serum thymidine kinase 1 and cancer

XU  Wen-Jing, LIU  De-Gan   

  1. Department of Oncology, Xinghua People's Hospital of Jiangsu Province, Xinghua 225700, China
  • Online:2013-09-08 Published:2013-09-16
  • Contact: Corresponding author: XU Wen-jing, E-mail: 2007xuwenjing@163.com E-mail:2007xuwenjing@163.com

Abstract: Thymidine kinase 1 (TK1), an enzyme of the pyrimidine remedial pathway, can catalyze phosphorylation of thymidine to thymidine monophosphate. It is closely related to cell cycle regulation and cell proliferation. A number of experiments show that TK1 can be used for physical examination, tumor screening, routine testing, effect monitoring and prognosis, which is considered to be a sensitive and useful marker for human tumor growth.

Key words: Neoplasms, Thymidine kinase, Immunohistochemistry